Figure 1From: A pilot study of rivastigmine in the treatment of delirium after stroke: A safe alternative DRS values according to treatment status. Figure one shows the course of the DRS, visualized at three points. Every patient is shown with an X. The first point is the DRS the day rivastigmine is started, the second is at maximum dose of rivastigmine and the last is after tapering off rivastigmine.Back to article page